the use of erythropoietin and iron preparations for the manufacture of pharmaceutical liitpreparaadi, pharmaceutical unit dose pack and method for the determination of the rauaseisundi body fluid sample

摘要

The present invention is directed to a pharmaceutical combination preparation comprising 2,000-7,000 U of recombinant human erythropoietin (EPO) and 5-20 mg of an Fe(III) complex, wherein the rhEPO and the Fe(III) complex may be present in separate administration forms or in an integrated administration form.The pharmaceutical preparation is used in the treatment of anemias or hemodialysis patients.